Polynucleotides encoding IL-31 monoclonal antibodies
AssigneesZymoGenetics, Inc., Merck Serono S/A
InventorsKent Bondensgaard, Roland Beckmann
Life of this patent
Estimating the term…
Abstract
The invention provides humanized mouse anti-human IL-31 antibodies and antibody fragments that are capable of binding IL-31 and thereby neutralizing, inhibiting, limiting, or reducing the proinflammatory or pro-pruritic effects of IL-31.
Claims30
An isolated nucleic acid molecule encoding a monoclonal antibody that specifically binds to human IL-31, wherein the encoded monoclonal antibody comprises a heavy chain variable domain and a light chain variable domain, wherein the heavy chain variable domain and the light chain variable domain each comprises a complementarity determining region (CDR) and a framework region (FR), wherein the heavy chain variable domain complementarity determining region comprises:
- a) a CDR1 having the amino acid residues of SEQ ID NO:1;
- b) a CDR2 having the amino acid residues of SEQ ID NO:2;
- and
- c) a CDR3 having the amino acid residues of SEQ ID NO:3;
- wherein the heavy chain variable domain framework region comprises:
- d) a FR1 having at least 90% sequence identity with amino acid residues of SEQ ID NO:12;
- e) a FR2 having at least 90% sequence identity with amino acid residues of SEQ ID NO:13;
- f) a FR3 having at least 90% sequence identity with amino acid residues of SEQ ID NO:14;
- and
- g) a FR4 having at least 90% sequence identity with amino acid residues of SEQ ID NO:15;
- wherein the light chain variable domain complementarity determining region comprises:
- h) a CDR1 having the amino acid residues of SEQ ID NO:5;
- i) a CDR2 having the amino acid residues of SEQ ID NO:6;
- and
- j) a CDR3 having the amino acid residues of SEQ ID NO:7;
- and
- wherein the light chain variable domain framework region comprises:
- k) a FR5 having at least 90% sequence identity with amino acid residues of SEQ ID NO:17;
- l) a FR6 having at least 90% sequence identity with amino acid residues of SEQ ID NO:18;
- m) a FR7 having at least 90% sequence identity with amino acid residues of SEQ ID NO:19;
- and
- n) a FR8 having at least 90% sequence identity with amino acid residues of SEQ ID NO:20.
An isolated nucleic acid molecule encoding a monoclonal antibody that specifically binds to human IL-31, wherein the encoded monoclonal antibody comprises a heavy chain variable domain and a light chain variable domain, wherein the heavy chain variable domain comprises the amino acid residues of SEQ ID NO:44 and the light chain variable domain comprises the amino acid residues of SEQ ID NO:26.
Dependencies are inferred from the claim text.